Trump's nomination of Heidi Overton sparks major health policy debate.
Overton's background raises concerns about health safety regulations.
Political tensions intensify with the Kennedy Center's naming decision.
Congress's division complicates health policy discussions ahead.
The FDA's future hangs in the balance of Overton's confirmation.